A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response.

Clin Transl Med

Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Published: January 2025

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686334PMC
http://dx.doi.org/10.1002/ctm2.70154DOI Listing

Publication Analysis

Top Keywords

paradigm cancer
4
cancer immunotherapy
4
immunotherapy orchestrating
4
orchestrating type
4
type type
4
type immunity
4
immunity curative
4
curative response
4
type
2
paradigm
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!